skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: good morning everyone at 5i: I would like to increase my exposure to Canadian equities- will you provide etfs, or tmx be a good option, or perhaps one best stock in each sector- . thanks for your time-- Jane
Read Answer Asked by jane on April 09, 2022
Q: With all the supply chain issues, and supply chain management being KXS specialty why was the stock flat in 2021, and down 2022. Supply chain issues persist, KXS does not appear to be capitalizing. Will revenue and share price improve through this year? I know it has been mentioned they have lumpy earnings but the conditions for their products should be very strong.
What am I missing on KXS?

Thank you, Mike
Read Answer Asked by Mike on April 08, 2022
Q: I can't understand why GSY iat a 52 week LOW. Yes high growth stocks and NASDAQ are going down. GSY has a PE close to 10. It is a value stock not a crazy growth stock. It is making money and yet it is being treated like a .COM stock.
Easy answer would be, the market thinks recession is coming and GSY will not perform well.
Do you have any explanation for GSY being at a 52 week low despite beating all estimates on quarterly results?
Thanks
Read Answer Asked by Herm on April 08, 2022
Q: Hello team,

Ross Healy was on BNN and suggested that BAM is valued at the absolute top end of it’s range “the stock is at 2x book value which is at a high over the last 15 years”. Not done he then added “the 2022 earnings have gone right into the ditch and our FMV has cratered with it, it’s no wonder shares are softening.”

I follow Brookfield as closely as anyone and earnings going in a ditch? I see a beat on DE, FFO, increased flows from private funds. I see increased tailwinds from the spin off to the transition fund to the increased fee bearing capital and continued capital deployment. Also, I see the CURRENT NAV at $68 a share so a ~13% discount.

Needless to say I am on the polar opposite side of his commentary.

What am I missing hear and can you please elaborate on his argument.

Thank you.

Read Answer Asked by James on April 05, 2022
Q: The following was in the Globe today and I quote: "Canaccord Genuity’s Doug Taylor lowered his Well Health Technologies Corp. to $10 from $12 with a “buy” rating, while PI Financial’s Kris Thompson cut his target to $9 from $10.50 with a “buy” rating. The AVERAGE is $10.12."

And yet is sits at $5.10. After a good, solid quarter. I just shake my head and wonder what I am missing?

If it wasn't for 5i I would have all my money in a sock hidden under the mattress.
Read Answer Asked by Bryan on April 05, 2022